← Back to Clinical Trials
Recruiting NCT04091724

NCT04091724 Perioperative EEG-Monitoring and Emergence Delirium in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04091724
Status Recruiting
Phase
Sponsor Huazhong University of Science and Technology
Condition Delirium
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2019-12-02
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 16 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2019-12-02 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Emergence delirium is a significant problem, particularly in children. However the incidence, preventative strategies, and management of emergence delirium remain unclear. Multichannel electroencephalogram is a recognized tool for identifying neurophysiologic states during anesthesia, sleep, and arousal. The aim of the current study is to evaluate the mechanisms and predictors of emergence delirium in children under 16 years scheduled for elective surgery using electroencephalogram. The "Pediatric Anesthesia Emergence Delirium Scores (PAED Score)" (Sikich et al. 2004) is used to screen for the occurrence of emergence delirium in the post anesthesia care unit.

Eligibility Criteria

Inclusion Criteria: 1. male or female children aged under 16 years 2. planned elective surgery 3. informed consent by parents or legal guardians Exclusion Criteria: 1. history of neurological or psychiatric disease 2. delayed development 3. inability of the parents or legal guardians to speak or read Chinese 4. participation in another prospective interventional clinical study during this study

Contact & Investigator

Central Contact

Hua Zheng, M.D.

✉ hzheng@hust.edu.cn

📞 0086-27-83663173

Frequently Asked Questions

Who can join the NCT04091724 clinical trial?

This trial is open to participants of all sexes, up to 16 Years, studying Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04091724 currently recruiting?

Yes, NCT04091724 is actively recruiting participants. Contact the research team at hzheng@hust.edu.cn for enrollment information.

Where is the NCT04091724 trial being conducted?

This trial is being conducted at Wuhan, China.

Who is sponsoring the NCT04091724 clinical trial?

NCT04091724 is sponsored by Huazhong University of Science and Technology. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology